A Brief History of the Proper Time for Antiplatelet Therapy in Peripheral Revascularization

被引：2
|
作者：
Vlachopoulos, Charalambos [1 ]
Terentes-Printzios, Dimitrios [1 ]
Aboyans, Victor [2 ,3 ]
机构：
[1] Univ Athens, Hypertens & Cardiometab Unit, Dept Cardiol 1, Hippokrat Hosp, Athens, Greece
[2] CHU Limoges, Hop Dupuytren, Serv Cardiol, Limoges, France
[3] Fac Med Limoges, INSERM 1094, Limoges, France
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2019年 / 12卷 / 23期
关键词：
antiplatelets; peripheral arterial disease; revascularization; ARTERY-DISEASE;
D O I：
10.1016/j.jcin.2019.09.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2371 / 2374
页数：4
相关论文
共 50 条
  • [1] Dual Antiplatelet Therapy in Peripheral Arterial Disease and After Peripheral Percutaneous Revascularization
    Hanna, Elias B.
    JOURNAL OF INVASIVE CARDIOLOGY, 2012, 24 (12): : 679 - 684
  • [2] It is time to rethink the dual antiplatelet therapy indication in revascularization surgery
    Bono, Julio O. E.
    Bratti, Juan P. Ricarte
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2023, 52 (01): : 5 - 7
  • [3] The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization
    Banerjee, Subhash
    Sarode, Karan
    Vinas, Ariel
    Banerjee, Avantika
    Mohammad, Atif
    Brilakis, Emmanouil S.
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (05) : 525 - 535
  • [4] Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease
    Cho, Sungsoo
    Lee, Yong-Joon
    Ko, Young-Guk
    Kang, Tae Soo
    Lim, Seong-Hoon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (23) : 2359 - 2370
  • [5] DUAL ANTIPLATELET THERAPY RESPONSIVENESS IN PATIENTS UNDERGOING PERCUTANEOUS REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    Kliger, Chad
    Babaev, Anvar
    Shah, Binita
    Feit, Frederick
    Slater, James
    Attubato, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E2049 - E2049
  • [6] Oral antiplatelet therapy for percutaneous coronary revascularization
    Hamdalla, Hussam
    Steinhubl, Steven R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (05) : 637 - 642
  • [7] PRIMARY NONADHERENCE TO ANTIPLATELET THERAPY AFTER REVASCULARIZATION
    Torres, N.
    Medaglio, D.
    Glasgow, J.
    Flaherty, J.
    Walsh, D.
    Fawcett, M.
    Wu, P.
    Pigeon, L.
    Reitz, J.
    Elliott, D.
    VALUE IN HEALTH, 2018, 21 : S64 - S64
  • [8] RENOVACULAR HYPERTENSIN TREATED WITH PERCUTANEOUS REVASCULARIZATION: STENT RESTENOSIS AND DOUBLE ANTIPLATELET THERAPY TIME
    Rodenas Galvez, Ana Cristina
    Perez Suarez, German
    Batista Garcia, Fatima
    Rivero, Yaiza
    Fernandez Granados, Saulo
    Cubillo Prieto, Daniel
    De Laguna Taboada, Alexis Bravo
    Aguilar Tejedor, Yeray
    Buceta Cacabelos, Enrique
    Garcia, Cesar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 385 - 385
  • [9] EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY AFTER PERIPHERAL ARTERY REVASCULARIZATION: INSIGHTS FROM VOYAGER PAD
    Hess, Connie Ng
    Berkowitz, Scott D.
    Debus, E. Sebastian
    Nehler, Mark
    Patel, Manesh R.
    Anand, Sonia
    Szarek, Michael
    Haskell, Lloyd
    Muehlhofer, Eva
    Bauersachs, Rupert
    Bonaca, Marc P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2213 - 2213
  • [10] ANTIPLATELET THERAPY FOLLOWING CORONARY REVASCULARIZATION - IS THE GOAL ACHIEVED
    RATNATUNGA, CP
    REES, GM
    KOVACS, IB
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1079 - 1079
12345